BTK Degrader
Showing 1 - 25 of 161
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +7 more
-
Manchester, United Kingdom
- +2 more
Aug 11, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
-
Duarte, California
- +10 more
Jul 14, 2022
Relapsed/Refractory B-cell Malignancies Trial (AC676)
Not yet recruiting
- Relapsed/Refractory B-cell Malignancies
- (no location specified)
Mar 27, 2023
B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)
Recruiting
- B-cell Malignancy, Low-grade
- +4 more
-
Beijing, Beijing, China
- +8 more
Jul 20, 2022
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in United States
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
-
San Francisco, California
- +5 more
Nov 1, 2023
CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)
Not yet recruiting
- CLL/SLL
- lisaftoclax +BTK inhibitor
- BTK inhibitor
- (no location specified)
Oct 26, 2023
Mature B Cell Tumors Trial in Tianjin (SHR1459)
Active, not recruiting
- Mature B Cell Neoplasms
-
Tianjin, Tianjin, ChinaBlood disease hospital of Chinese Academy of Medical Sciences
Nov 10, 2022
The Cre8™ BTK Post Market Clinical Follow-up Study
Not yet recruiting
- Peripheral Arterial Disease
- Cre8™ BTK
-
Abano Terme, Padova, Italy
- +1 more
Nov 8, 2022
Atrial Fibrillation Trial in Caen (Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®))
Not yet recruiting
- Atrial Fibrillation
- Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Sep 6, 2023
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 20, 2023
Critical Limb Ischemia (CLI) Trial in Australia, Taiwan, United States (Esprit BTK Device)
Recruiting
- Critical Limb Ischemia (CLI)
- Esprit BTK Device
-
South Dartmouth, Massachusetts
- +4 more
Apr 26, 2022
Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)
Active, not recruiting
- Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- TG-1701
- +2 more
-
East Melbourne, Victoria, Australia
- +7 more
Jan 20, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Boston, Massachusetts
- +11 more
Nov 23, 2022
Recurrent Refractory Mantle Cell Lymphoma
Recruiting
- Mantle Cell Lymphoma
-
Beijing, Beijing, ChinaPeking University Third Hospital
Aug 1, 2022
Sjögren Syndrome Trial in Worldwide (LOU064, Placebo)
Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)
Completed
- Chronic Lymphocytic Leukemia (CLL)
- Waldenstrom Macroglobulinemia (WM)
- Shingrix vaccine
-
Rochester, New YorkUniversity of Rochester
Jan 9, 2023
Newly Diagnosed Mantle Cell Lymphoma Trial in Zhengzhou (Rituximab)
Recruiting
- Newly Diagnosed Mantle Cell Lymphoma
-
Zhengzhou, Henan, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzh
Aug 17, 2022
B-Cell Malignancies Trial (TT-01488 Tablets)
Not yet recruiting
- B-Cell Malignancies
- TT-01488 Tablets
- (no location specified)
Jan 4, 2023
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Orelabrutinib)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Mar 16, 2022
CNS Lymphoma Trial in Beijing (Zanubrutinib)
Recruiting
- CNS Lymphoma
-
Beijing, Beijing, ChinaPeking University People's Hospital
Aug 1, 2022
Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)
Not yet recruiting
- Waldenstrom Macroglobulinemia
- B-Cell Lymphoproliferative Disorder
- Pirtobrutinib
- +2 more
-
Boston, Massachusetts
- +2 more
Feb 18, 2023